Thinle Chodon to Immunotherapy, Active
This is a "connection" page, showing publications Thinle Chodon has written about Immunotherapy, Active.
Connection Strength
0.506
-
Active Immunotherapy of Cancer. Immunol Invest. 2015; 44(8):817-36.
Score: 0.484
-
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro. Clin Immunol. 2010 Sep; 136(3):338-47.
Score: 0.022